VRCA
VRCA
NASDAQ · Pharmaceuticals

Verrica Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$4.50
-0.35 (-7.22%)
As of Mar 24, 4:31 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +113.1% upside
Low Target $7.88
Average Target $9.59
High Target $13.36
Current Price $4.50
Current
$4.50
Target
$9.59
$7.88 $9.59 avg $13.36
Scenario Analysis
Bear Case
$7.88
75.1%
Low target
Base Case
$9.59
+113.1%
Avg target
Bull Case
$13.36
+196.9%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$9.82
-54.2% from high
52-Week Low
$3.28
+37.2% from low
Target vs 52W High
$9.59
-2.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%